Nerve Growth Factor (NGF), also known as Beta-NGF, is an endogenous neurotrophin primarily produced in the central and peripheral nervous systems. It belongs to the chemical class of growth factors and is crucial for the survival, development, and function of neurons. NGF is synthesized by various cell types, including neurons, immune cells, and epithelial cells, and is found in seminal plasma, highlighting its diverse physiological roles. Researchers have observed that NGF plays a pivotal role in sensory innervation, tissue repair, and immunoregulation. It is involved in the modulation of inflammation and has been studied for its potential in promoting tissue regeneration, particularly in bone and neural tissues. NGF also influences mesenchymal stem/stromal cells (MSCs), affecting their survival, growth, and differentiation. The mechanism of action of NGF involves binding to its high-affinity receptor TrkA and low-affinity receptor p75NTR, initiating signaling pathways that promote neuronal survival and differentiation. In reproductive biology, NGF has been identified as an ovulation-inducing factor in camelids and is being explored for its luteotropic effects in bovine species. Pharmacokinetic properties of NGF, such as half-life and metabolism, are not well-documented in the literature. However, recombinant human NGF has been used in clinical trials for ocular conditions like neurotrophic keratopathy and glaucoma, demonstrating safety and efficacy. NGF's potential as a treatment for pediatric eye diseases and as an analgesic for pain management is under investigation. Regulatory standing varies by region, with ongoing research into its therapeutic applications.